Long-Term Study of Treatment Methods and Outcomes in Adults with Acromegaly in China

What this Trial Is About

Researchers are conducting a long-term observational study in China to better understand how acromegaly is treated and how different treatments affect patient outcomes and costs. The study aims to answer important questions about treatment methods, their impact on patients health, and economic considerations, helping to inform future care decisions for people with acromegaly. Participants receive care guided by their doctors without interference from the study. Treatments include surgical options like transnasal butterfly surgery, drug therapies such as somatostatin analogues including sandostatin and lanreotide, dopamine receptor agonists, GH receptor antagonists, and various radiotherapy methods like linear accelerator X knife and gamma knife. The study observes these treatments without assigning or changing patient care. During the study, patient medical information is collected confidentially over up to 30 years. Researchers will assess clinical outcomes including overall survival, control of growth hormone levels, and cost-effectiveness of treatments. No changes to patient care occur, and privacy is maintained following international standards. This long-term monitoring helps provide valuable insights into acromegaly management.

The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research